how to cite:
Nasri
H , Rafieian-Kopaei
M. Metformin and Diabetic Kidney Disease: A Mini-Review on Recent Findings. Iran J Pediatr. 2014;24(5): 565-568.
Abstract
Metformin, an oral anti-diabetic agent in the biguanide class is a widely prescribed drug to treat high blood glucose in patients with type 2 diabetes mellitus. Metformin has three different roles, including blood glucose regulatory effect, protection of kidney tubular cell by acting as an effective antioxidant and finally ameliorative effect on diabetic kidney disease through saving the podocytes. Therefore, diabetic patients may benefit from all of these three distinct ameliorative effects.
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you.